摘要 |
Pharmaceutical compositions containing as the active ingredient heterocyclic compounds represented by the general formula (|), isomers or solvates thereof, or pharmaceutically acceptable salts of them exhibit excellent TNF-a production inhibiting activity and are therefore useful in the prevention and treatment of various diseases caused by abnormal production of TNF-a: (|) wherein R1 is optionally substituted alkyl, aryl, heteroaryl, or the like; R2 and R3 are each hydrogen, hydroxyl, optionally substituted alkyl, or the like; R4 is hydrogen, optionally substituted alkyl, or the like; X is hydrogen, halogeno, hydroxyl, optionally substituted alkyl, aryl, heteroaryl, amino, or the like; and Y is oxygen or sulfur.
|
申请人 |
AJINOMOTO CO., INC.;TANAKA, YASUHIRO;FUJITA, KOHICHI;CHUJOH, YOSHITOMO;FUKUDA, SYUNSUKE;IKENOUE, YUKA;TAGAMI, TOMOYUKI;CHIBA, AKIRA;KODAIRA, ARIKO;MATSUMOTO, HIDEKI;NAKAGAWA, TADAKIYO;YAMADA, TATSUHIRO;SUZUKI, MANABU;MURATA, MASAHIRO |
发明人 |
TANAKA, YASUHIRO;FUJITA, KOHICHI;CHUJOH, YOSHITOMO;FUKUDA, SYUNSUKE;IKENOUE, YUKA;TAGAMI, TOMOYUKI;CHIBA, AKIRA;KODAIRA, ARIKO;MATSUMOTO, HIDEKI;NAKAGAWA, TADAKIYO;YAMADA, TATSUHIRO;SUZUKI, MANABU;MURATA, MASAHIRO |